{"id":185325,"name":"DR. REDDY'S LABORATORIES, LTD","slug":"dr-reddys-laboratories-ltd","state":"NJ","country":"United States of America","description":"Medical Laboratory","totalSpending":1755000,"filings":32,"yearlySpending":[{"year":2018,"income":180000},{"year":2019,"income":180000},{"year":2020,"income":195000},{"year":2021,"income":240000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":["PHA"],"firms":["RUBICON ADVISORS, LLC"],"lobbyists":["WILLIAM BURKE","KATHY KULKARNI"],"govEntities":["Drug Enforcement Administration (DEA)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE"],"sampleDescriptions":["Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues","Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues","Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues","Prescription Drug User Fee Act (PDUFA) reauthorization. Generic Drug User Fee Act (GDUFA) reauthorization. Border Adjustment Tax (BAT) issues","Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}